Adaptive Biotechnologies
Kyle Piskel currently serves as Chief Financial Officer at Adaptive Biotechnologies Corp., having held multiple roles within the company since September 2015, including Principal Accounting Officer and Vice President of Accounting. Prior to this, Kyle gained experience at Expedia, Inc. as Manager of Financial Reporting from November 2014 to August 2015 and at Ernst & Young from August 2007 to October 2014, where Kyle progressed through various positions including Assurance Manager and Assurance Senior. Kyle holds a Master’s of Accountancy from Gonzaga University - School of Business Administration and a Bachelor’s degree in Accounting from Eastern Washington University.
Adaptive Biotechnologies
17 followers
Adaptive Biotechnologies is a pioneer and leader in immune-driven medicine that aims to improve people’s lives by learning from the wisdom of their adaptive immune systems. Adaptive’s proprietary immune profiling platform reveals and translates insights from our adaptive immune systems with unprecedented scale and precision.